Latest debt-to-equity ratio for PaxMedica: -0.28 — see history and peer comparisons.
Get informed when a big investor buys or sells
+ Follow-0.28
Debt-to-Equity ratio measures a company's financial leverage by comparing its total debt to shareholder equity. A lower D/E ratio generally indicates a more financially stable company with less risk.
As of the most recent data, PXMD shows a debt-to-equity ratio of -0.28. That is below the sector sector average of 0.2. Scroll down for historical charts and peer comparison views.
The its sector sector average debt-to-equity ratio is about 0.2. PaxMedica is at -0.28, which is lower that average. That is roughly 238.1% below the sector mean. Use the comparison chart on this page to see how PXMD stacks up against individual peers as well.
Investors watch PXMD's debt-to-equity ratio because it compresses price and fundamentals into one number that is easy to compare across companies and over time. PaxMedica's latest reading is -0.28. Combining that with growth, ROE, and debt metrics usually beats relying on a single multiple.
Besides this debt-to-equity ratio page, Stockcircle has PaxMedica's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect debt-to-equity ratio (currently -0.28) with ownership activity and broader fundamentals.